Spinal muscular atrophy: New findings for an old pathology

Brain Pathology

Volumn 23, Issue 6, 2013, Pages 613-622

  Bottai, Daniele ^a   Adami, Raffaella ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

cardiotrophin 1; miRNA; muscle activity; NMJ; SMN1; SMN2; spinal muscular atrophy

Indexed keywords

ALPHA ACTININ; ALPHA CRYSTALLIN; CARDIOTROPHIN 1; CHOLINERGIC RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; JANUS KINASE; MICRORNA; MICRORNA 1; MICRORNA 133A; MICRORNA 9; SMALL NUCLEAR RIBONUCLEOPROTEIN; STAT PROTEIN; SURVIVAL MOTOR NEURON PROTEIN 1; UNCLASSIFIED DRUG;

BRAIN NERVE CELL; CELL INTERACTION; CELL MIGRATION; CELL SURVIVAL; CHOLINERGIC NERVE CELL; DENDRITE; GENE; GENE EXPRESSION; HUMAN; LOSS OF FUNCTION MUTATION; MUSCLE CELL; MUSCLE CONTRACTION; MUSCLE NECROSIS; MUSCLE TRAINING; MYOTUBE; NERVE CELL DIFFERENTIATION; NERVE COMPRESSION; NERVE FIBER GROWTH; NERVE FIBER TRANSPORT; NEUROMUSCULAR SYNAPSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PC12 CELL; PHENOTYPE; PHYSICAL INACTIVITY; PROTEIN DEPLETION; PROTEIN FUNCTION; REVIEW; SPINAL CORD; SPINAL GANGLION; SPINAL MUSCULAR ATROPHY; SURVIVAL MOTOR NEURON GENE 1; SYNAPTIC TRANSMISSION;

CARDIOTROPHIN 1; MIRNA; MUSCLE ACTIVITY; NMJ; SMN1; SMN2; SPINAL MUSCULAR ATROPHY;

HUMANS; MOTOR NEURONS; NEURONS; SPINAL MUSCULAR ATROPHIES OF CHILDHOOD; SURVIVAL OF MOTOR NEURON 1 PROTEIN;

EID: 84885622197     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12071     Document Type: Review

References (90)

1. Alexianu ME, Ho BK, Mohamed AH, La Bella V, Smith RG, Appel SH, (1994) The role of calcium-binding proteins in selective motor neuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol 36: 846-858.
2. Bolliger MF, Zurlinden A, Luscher D, Butikofer L, Shakhova O, Francolini M, et al (2010) Specific proteolytic cleavage of agrin regulates maturation of the neuromuscular junction. J Cell Sci 123: 3944-3955.
3. Bordet T, Lesbordes JC, Rouhani S, Castelnau-Ptakhine L, Schmalbruch H, Haase G, Kahn A, (2001) Protective effects of cardiotrophin-1 adenoviral gene transfer on neuromuscular degeneration in transgenic ALS mice. Hum Mol Genet 10: 1925-1933.
4. Boulisfane N, Choleza M, Rage F, Neel H, Soret J, Bordonne R, (2011) Impaired minor tri-snRNP assembly generates differential splicing defects of U12-type introns in lymphoblasts derived from a type I SMA patient. Hum Mol Genet 20: 641-648.
5. Bowerman M, Anderson CL, Beauvais A, Boyl PP, Witke W, Kothary R, (2009) SMN, profilin IIa and plastin 3: a link between the deregulation of actin dynamics and SMA pathogenesis. Mol Cell Neurosci 42: 66-74.
6. Braun S, Croizat B, Lagrange MC, Poindron P, Warter JM, (1997) Degeneration of cocultures of spinal muscular atrophy muscle cells and rat spinal cord explants is not due to secreted factors and cannot be prevented by neurotrophins. Muscle Nerve 20: 953-960.
7. Braun S, Croizat B, Lagrange MC, Warter JM, Poindron P, (1995) Constitutive muscular abnormalities in culture in spinal muscular atrophy. Lancet 345: 694-695.
8. Bronnum-Hansen H, Juel K, Davidsen M, Sorensen J, (2007) Impact of selected risk factors on expected lifetime without long-standing, limiting illness in Denmark. Prev Med 45: 49-53.
9. Brzustowicz LM, Lehner T, Castilla LH, Penchaszadeh GK, Wilhelmsen KC, Daniels R, et al (1990) Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature 344: 540-541.
10. Bsibsi M, Bajramovic JJ, Vogt MH, van Duijvenvoorden E, Baghat A, Persoon-Deen C, et al (2010) The microtubule regulator stathmin is an endogenous protein agonist for TLR3. J Immunol 184: 6929-6937.
11. Burge CB, Padgett RA, Sharp PA, (1998) Evolutionary fates and origins of U12-type introns. Mol Cell 2: 773-785.
12. Burglen L, Lefebvre S, Clermont O, Burlet P, Viollet L, Cruaud C, et al (1996) Structure and organization of the human survival motor neurone (SMN) gene. Genomics 32: 479-482.
13. Burglen L, Spiegel R, Ignatius J, Cobben JM, Landrieu P, Lefebvre S, et al (1995) SMN gene deletion in variant of infantile spinal muscular atrophy. Lancet 346: 316-317.
14. Burlet P, Huber C, Bertrandy S, Ludosky MA, Zwaenepoel I, Clermont O, et al (1998) The distribution of SMN protein complex in human fetal tissues and its alteration in spinal muscular atrophy. Hum Mol Genet 7: 1927-1933.
15. Campbell L, Potter A, Ignatius J, Dubowitz V, Davies K, (1997) Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am J Hum Genet 61: 40-50.
16. Cifuentes-Diaz C, Frugier T, Tiziano FD, Lacene E, Roblot N, Joshi V, et al (2001) Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy. J Cell Biol 152: 1107-1114.
17. Cifuentes-Diaz C, Nicole S, Velasco ME, Borra-Cebrian C, Panozzo C, Frugier T, et al (2002) Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model. Hum Mol Genet 11: 1439-1447.
18. Conforti L, Adalbert R, Coleman MP, (2007) Neuronal death: where does the end begin? Trends Neurosci 30: 159-166.
19. Crawford TO, Sladky JT, Hurko O, Besner-Johnston A, Kelley RI, (1999) Abnormal fatty acid metabolism in childhood spinal muscular atrophy. Ann Neurol 45: 337-343.
20. Dachs E, Hereu M, Piedrafita L, Casanovas A, Caldero J, Esquerda JE, (2011) Defective neuromuscular junction organization and postnatal myogenesis in mice with severe spinal muscular atrophy. J Neuropathol Exp Neurol 70: 444-461.
21. Dale JM, Shen H, Barry DM, Garcia VB, Rose FF Jr, Lorson CL, Garcia ML, (2011) The spinal muscular atrophy mouse model, SMADelta7, displays altered axonal transport without global neurofilament alterations. Acta Neuropathol 122: 331-341.
22. Delaloy C, Gao FB, (2010) A new role for microRNA-9 in human neural progenitor cells. Cell Cycle 9: 2913-2914.
23. den Engelsman J, Gerrits D, de Jong WW, Robbins J, Kato K, Boelens WC, (2005) Nuclear import of {alpha}B-crystallin is phosphorylation-dependent and hampered by hyperphosphorylation of the myopathy-related mutant R120G. J Biol Chem 280: 37139-37148.
24. DiDonato CJ, Lorson CL, De Repentigny Y, Simard L, Chartrand C, Androphy EJ, Kothary R, (2001) Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing. Hum Mol Genet 10: 2727-2736.
25. Fischer U, Liu Q, Dreyfuss G, (1997) The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell 90: 1023-1029.
26. Foust KD, Wang X, McGovern VL, Braun L, Bevan AK, Haidet AM, et al (2010) Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat Biotechnol 28: 271-274.
27. Gabanella F, Butchbach ME, Saieva L, Carissimi C, Burghes AH, Pellizzoni L, (2007) Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs. PLoS One 2: e921.
28. Gavrilina TO, McGovern VL, Workman E, Crawford TO, Gogliotti RG, DiDonato CJ, et al (2008) Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect. Hum Mol Genet 17: 1063-1075.
29. Gavrilov DK, Shi X, Das K, Gilliam TC, Wang CH, (1998) Differential SMN2 expression associated with SMA severity. Nat Genet 20: 230-231.
30. Gilliam TC, Brzustowicz LM, Castilla LH, Lehner T, Penchaszadeh GK, Daniels RJ, et al (1990) Genetic homogeneity between acute and chronic forms of spinal muscular atrophy. Nature 345: 823-825.
31. Haramati S, Chapnik E, Sztainberg Y, Eilam R, Zwang R, Gershoni N, et al (2010) miRNA malfunction causes spinal motor neuron disease. Proc Natl Acad Sci U S A 107: 13111-13116.
32. Imlach WL, Beck ES, Choi BJ, Lotti F, Pellizzoni L, McCabe BD, (2012) SMN Is Required for Sensory-Motor Circuit Function in Drosophila. Cell 151: 427-439.
33. Kariya S, Park GH, Maeno-Hikichi Y, Leykekhman O, Lutz C, Arkovitz MS, et al (2008) Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum Mol Genet 17: 2552-2569.
34. Keller C, Steensberg A, Pilegaard H, Osada T, Saltin B, Pedersen BK, Neufer PD, (2001) Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J 15: 2748-2750.
35. Kelley RI, Sladky JT, (1986) Dicarboxylic aciduria in an infant with spinal muscular atrophy. Ann Neurol 20: 734-736.
36. Kelly AM, Rubinstein NA, (1994) The diversity of muscle fiber types and its origin during development. In: Myology: Basic and Clinica, AG Engel, (ed.), pp. 119-133. McGraw-Hill: New York.
37. Kinali M, Banks LM, Mercuri E, Manzur AY, Muntoni F, (2004) Bone mineral density in a paediatric spinal muscular atrophy population. Neuropediatrics 35: 325-328.
38. Kong L, Wang X, Choe DW, Polley M, Burnett BG, Bosch-Marce M, et al (2009) Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J Neurosci 29: 842-851.
39. Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80: 155-165.
40. Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, Munnich A, et al (1997) Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 16: 265-269.
41. Lesbordes JC, Cifuentes-Diaz C, Miroglio A, Joshi V, Bordet T, Kahn A, Melki J, (2003) Therapeutic benefits of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy. Hum Mol Genet 12: 1233-1239.
42. Levine A, Durbin R, (2001) A computational scan for U12-dependent introns in the human genome sequence. Nucleic Acids Res 29: 4006-4013.
43. Limongelli G, Calabro P, Maddaloni V, Russo A, Masarone D, D'Aponte A, et al (2010) Cardiotrophin-1 and TNF-alpha circulating levels at rest and during cardiopulmonary exercise test in athletes and healthy individuals. Cytokine 50: 245-247.
44. Ling KK, Lin MY, Zingg B, Feng Z, Ko CP, (2010) Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy. PLoS One 5: e15457.
45. Ling KK, Gibbs RM, Feng Z, Ko CP, (2012) Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy. Hum Mol Genet 21: 185-195.
46. Liu H, Beauvais A, Baker AN, Tsilfidis C, Kothary R, (2011) Smn deficiency causes neuritogenesis and neurogenesis defects in the retinal neurons of a mouse model of spinal muscular atrophy. Dev Neurobiol 71: 153-169.
47. Liu Q, Dreyfuss G, (1996) A novel nuclear structure containing the survival of motor neurons protein. EMBO J 15: 3555-3565.
48. Liu Q, Fischer U, Wang F, Dreyfuss G, (1997) The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell 90: 1013-1021.
49. Lorson CL, Androphy EJ, (2000) An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum Mol Genet 9: 259-265.
50. Lorson CL, Hahnen E, Androphy EJ, Wirth B, (1999) A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A 96: 6307-6311.
51. Lotti F, Imlach WL, Saieva L, Beck ES, Hao Le T, Li DK, et al (2012) An SMN-dependent U12 splicing event essential for motor circuit function. Cell 151: 440-454.
52. Martinez-Hernandez R, Soler-Botija C, Also E, Alias L, Caselles L, Gich I, et al (2009) The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation. J Neuropathol Exp Neurol 68: 474-481.
53. McAndrew PE, Parsons DW, Simard LR, Rochette C, Ray PN, Mendell JR, et al (1997) Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet 60: 1411-1422.
54. Meister G, Eggert C, Fischer U, (2002) SMN-mediated assembly of RNPs: a complex story. Trends Cell Biol 12: 472-478.
55. Melki J, Abdelhak S, Sheth P, Bachelot MF, Burlet P, Marcadet A, et al (1990) Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q. Nature 344: 767-768.
56. Melki J, Sheth P, Abdelhak S, Burlet P, Bachelot MF, Lathrop MG, et al (1990) Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12-q14. The French Spinal Muscular Atrophy Investigators. Lancet 336: 271-273.
57. Mercuri E, Bertini E, Iannaccone ST, (2012) Childhood spinal muscular atrophy: controversies and challenges. Lancet Neurol 11: 443-452.
58. Middleton G, Hamanoue M, Enokido Y, Wyatt S, Pennica D, Jaffray E, et al (2000) Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons. J Cell Biol 148: 325-332.
59. Missias AC, Chu GC, Klocke BJ, Sanes JR, Merlie JP, (1996) Maturation of the acetylcholine receptor in skeletal muscle: regulation of the AChR gamma-to-epsilon Switch. Dev Biol 179: 223-238.
60. Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH, McPherson JD, (1999) A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 8: 1177-1183.
61. Munsat TL, Skerry L, Korf B, Pober B, Schapira Y, Gascon GG, et al (1990) Phenotypic heterogeneity of spinal muscular atrophy mapping to chromosome 5q11.2-13.3 (SMA 5q). Neurology 40: 1831-1836.
62. Nicole S, Desforges B, Millet G, Lesbordes J, Cifuentes-Diaz C, Vertes D, et al (2003) Intact satellite cells lead to remarkable protection against Smn gene defect in differentiated skeletal muscle. J Cell Biol 161: 571-582.
63. Novelli G, Calza L, Amicucci P, Giardino L, Pozza M, Silani V, et al (1997) Expression study of survival motor neuron gene in human fetal tissues. Biochem Mol Med 61: 102-106.
64. Otaegi G, Pollock A, Hong J, Sun T, (2011) MicroRNA miR-9 modifies motor neuron columns by a tuning regulation of FoxP1 levels in developing spinal cords. J Neurosci 31: 809-818.
65. Otaegi G, Pollock A, Sun T, (2011) An optimized sponge for microRNA miR-9 affects spinal motor neuron development in vivo. Front Neurosci 5: 146.
66. Patel AA, Steitz JA, (2003) Splicing double: insights from the second spliceosome. Nat Rev Mol Cell Biol 4: 960-970.
67. Patel AA, McCarthy M, Steitz JA, (2002) The splicing of U12-type introns can be a rate-limiting step in gene expression. EMBO J 21: 3804-3815.
68. Pedersen L, Pilegaard H, Hansen J, Brandt C, Adser H, Hidalgo J, et al (2011) Exercise-induced liver chemokine CXCL-1 expression is linked to muscle-derived interleukin-6 expression. J Physiol 589: 1409-1420.
69. Pellizzoni L, Kataoka N, Charroux B, Dreyfuss G, (1998) A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. Cell 95: 615-624.
70. Pennica D, Swanson TA, Shaw KJ, Kuang WJ, Gray CL, Beatty BG, Wood WI, (1996) Human cardiotrophin-1: protein and gene structure, biological and binding activities, and chromosomal localization. Cytokine 8: 183-189.
71. Pennica D, Wood WI, Chien KR, (1996) Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor-gp 130 dependent pathways. Cytokine Growth Factor Rev 7: 81-91.
72. Pessa HK, Ruokolainen A, Frilander MJ, (2006) The abundance of the spliceosomal snRNPs is not limiting the splicing of U12-type introns. RNA 12: 1883-1892.
73. Piccoli M, Franzin C, Bertin E, Urbani L, Blaauw B, Repele A, et al (2012) Amniotic Fluid Stem Cells Restore the Muscle Cell Niche in a HSA-Cre, Smn(F7/F7) Mouse Model. Stem Cells 30: 1675-1684.
74. Plomgaard P, Penkowa M, Pedersen BK, (2005) Fiber type specific expression of TNF-alpha, IL-6 and IL-18 in human skeletal muscles. Exerc Immunol Rev 11: 53-63.
75. Prior TW, Russman BS, (1993) Spinal Muscular Atrophy. 1993-2000 (Updated 2011 Jan 27) Edition. University of Washington: Seattle.
76. Qu Q, Shi Y, (2009) Neural stem cells in the developing and adult brains. J Cell Physiol 221: 5-9.
77. Rau CS, Jeng JC, Jeng SF, Lu TH, Chen YC, Liliang PC, et al (2010) Entrapment neuropathy results in different microRNA expression patterns from denervation injury in rats. BMC Musculoskelet Disord 11: 181.
78. Riessland M, Ackermann B, Forster A, Jakubik M, Hauke J, Garbes L, et al (2010) SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy. Hum Mol Genet 19: 1492-1506.
79. Rossoll W, Jablonka S, Andreassi C, Kroning AK, Karle K, Monani UR, Sendtner M, (2003) Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. J Cell Biol 163: 801-812.
80. Rudnik-Schoneborn S, Heller R, Berg C, Betzler C, Grimm T, Eggermann T, et al (2008) Congenital heart disease is a feature of severe infantile spinal muscular atrophy. J Med Genet 45: 635-638.
81. Ruiz R, Casanas JJ, Torres-Benito L, Cano R, Tabares L, (2010) Altered intracellular Ca2+ homeostasis in nerve terminals of severe spinal muscular atrophy mice. J Neurosci 30: 849-857.
82. Schrank B, Gotz R, Gunnersen JM, Ure JM, Toyka KV, Smith AG, Sendtner M, (1997) Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci U S A 94: 9920-9925.
83. Schwartz M, Sorensen N, Hansen FJ, Hertz JM, Norby S, Tranebjaerg L, Skovby F, (1997) Quantification, by solid-phase minisequencing, of the telomeric and centromeric copies of the survival motor neuron gene in families with spinal muscular atrophy. Hum Mol Genet 6: 99-104.
84. Shababi M, Habibi J, Yang HT, Vale SM, Sewell WA, Lorson CL, (2010) Cardiac defects contribute to the pathology of spinal muscular atrophy models. Hum Mol Genet 19: 4059-4071.
85. Strasswimmer J, Lorson CL, Breiding DE, Chen JJ, Le T, Burghes AH, Androphy EJ, (1999) Identification of survival motor neuron as a transcriptional activator-binding protein. Hum Mol Genet 8: 1219-1226.
86. Sugarman EA, Nagan N, Zhu H, Akmaev VR, Zhou Z, Rohlfs EM, et al (2012) Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens. Eur J Hum Genet 20: 27-32.
87. Tein I, Sloane AE, Donner EJ, Lehotay DC, Millington DS, Kelley RI, (1995) Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)? Pediatr Neurol 12: 21-30.
88. Velasco E, Valero C, Valero A, Moreno F, Hernandez-Chico C, (1996) Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of cBCD541 and SMA phenotype. Hum Mol Genet 5: 257-263.
89. Wen HL, Ting CH, Liu HC, Li H, Lin-Chao S, (2013) Decreased stathmin expression ameliorates neuromuscular defects but fails to prolong survival in a mouse model of spinal muscular atrophy. Neurobiol Dis 52: 94-103.
90. Yamanouchi Y, Yamanouchi H, Becker LE, (1996) Synaptic alterations of anterior horn cells in Werdnig-Hoffmann disease. Pediatr Neurol 15: 32-35.